Clinical Trial Update: Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation [Phase 2]

View source ↗

Summary

This update reports the termination of a Phase 2 clinical trial investigating removal of T cells to prevent graft-versus-host disease in bone marrow transplant …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Leukemia
• Multiple Myeloma and Plasma Cell Neoplasms
• Myelodysplastic Syndromes
• Myeloproliferative Disorders

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease | Phase 2 | Status: TERMINATED